{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:03:38Z","timestamp":1768705418188,"version":"3.49.0"},"reference-count":14,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,8,14]]},"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1183\/13993003.01494-2019","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T13:04:15Z","timestamp":1570712655000},"page":"1901494","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary?"],"prefix":"10.1183","volume":"54","author":[{"given":"Roland","family":"Diel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil W.","family":"Schluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2024101915312544000_54.4.1901494.1","unstructured":"World Health Organization (WHO). End TB Strategy www.who.int\/tb\/post2015_strategy\/en\/ Date last accessed: 21 July 2019."},{"key":"2024101915312544000_54.4.1901494.2","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2018. www.who.int\/tb\/publications\/global_report\/en\/ Date last accessed: 21 July 2019."},{"key":"2024101915312544000_54.4.1901494.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382301"},{"key":"2024101915312544000_54.4.1901494.4","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.16.0716"},{"key":"2024101915312544000_54.4.1901494.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000146"},{"key":"2024101915312544000_54.4.1901494.6","unstructured":"World Health Organization. WHO Treatment Guidelines for Isoniazid-resistant Tuberculosis: Online Annexes. Supplement to the WHO Treatment Guidelines for Drug-resistant Tuberculosis. www.who.int\/tb\/publications\/2018\/WHO_guidelines_isoniazid_resistant_TB\/en\/ Date last accessed: 21 July 2019. Last updated July 2018."},{"key":"2024101915312544000_54.4.1901494.7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-2600(18)30078-X","article-title":"Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis","volume":"6","author":"Fregonese","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024101915312544000_54.4.1901494.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.4.603"},{"key":"2024101915312544000_54.4.1901494.9","unstructured":"National Institute for Health and Care Excellence. Tuberculosis. www.nice.org.uk\/guidance\/ng33\/chapter\/recommendations#drugresistant-tb-excluding-multidrug-and-extensively-drugresistant-tb Date last accessed: 21 July 2019. Date last updated: 9 Jan 2016."},{"key":"2024101915312544000_54.4.1901494.10","unstructured":"Tuberculosis in Switzerland. Guide for Health Professionals, Version 3.2019. www.tbinfo.ch\/fileadmin\/user_upload\/1wissenszentrum\/Publikationen\/Handbuch_Tuberkulose\/Handbuch_TB_DE_16_05_19.pdf Date last accessed: 21 July 2019."},{"key":"2024101915312544000_54.4.1901494.11","first-page":"325","article-title":"[Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]","volume":"71","author":"Schaberg","year":"2017","journal-title":"Pneumologie"},{"key":"2024101915312544000_54.4.1901494.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00982-2019"},{"key":"2024101915312544000_54.4.1901494.13","unstructured":"U.S. Food and Drug Administration. Drug Safety Communication: FDA updates warning for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. Jul 10, 2018. www.fda.gov\/news-events\/press-announcments\/fda.updates-warnings-fluoroquinolone-antobiotics-risks-mental-health-and-low-blood-sugar-adverse. Date last accessed: July 21, 2019."},{"key":"2024101915312544000_54.4.1901494.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200901-0078OC"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01494-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:24:05Z","timestamp":1740381845000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01494-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,10,10]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1183\/13993003.01494-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01494-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}